ChromaCode Stock

chromacode.comHealthcare / BioTech & PharmaFounded: 2012

ChromaCode is a biotechnology company that specializes in developing molecular diagnostics solutions. Founded in 2012 and headquartered in Carlsbad, California, the company's core technology is based on proprietary mathematical algorithms that enable the simultaneous detection of multiple DNA and RNA targets in a single reaction. ChromaCode harnesses the power of data science and advanced algorithms aiming to enhance the accuracy, efficiency, and affordability of diagnostic testing. Their solutions encompass infectious disease testing, genetic testing, oncology diagnostics, and more. The company works closely with clinical laboratories, healthcare providers, and regulatory agencies to ensure that their solutions meet rigorous quality standards and regulatory requirements.

Register To Buy and Sell Shares

For more details on financing and valuation for ChromaCode, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access ChromaCode’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like ChromaCode.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

ChromaCode investors also invested in these private companies


Management Team

Mark McDonough
Chief Executive Officer
Aditya Rajagopal
PhD, Co-Founder and Chief Technical Officer
Padma Sundar
Chief Business Officer
Paul Flook
PhD, Chief Research and Development Officer
Chris MacDonald
PhD, Chief Scientific Officer

Board Members

Pat Smerkers
Northpond Ventures
Justin Klein
Vensana Capital
Jenny Yip
Adjuvant Capital

Frequently Asked Questions About ChromaCode’s Stock

Can you buy ChromaCode’s stock?
ChromaCode is not publicly traded on NYSE or NASDAQ in the U.S. To buy ChromaCode’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell ChromaCode’s stock?
Yes, you can sell stock of a private company like ChromaCode. Forge can help you sell your ChromaCode stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is ChromaCode’s stock price?
ChromaCode is a privately held company and therefore does not have a public stock price. However, you may access ChromaCode’s private market stock price with Forge Data.
What is ChromaCode’s stock ticker symbol?
ChromaCode does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: May 22, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.